Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs

Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs

European companies, a major source of U.S. medicines, are hopeful that their investments and trade deals with the U.S. will spare them from President Trump’s latest tariff barrage. continue reading...

Author
The New York Times

You May Also Like